US OptionsDetailed Quotes
BCTX241220C7500
- 0.05
- 0.000.00%
15min DelayClose Nov 29 13:00 ET
0.05High0.05Low
0.05Open0.05Pre Close1 Volume0 Open Interest7.50Strike Price5.00Turnover523.69%IV668.84%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1315Delta0.1830Gamma19.65Leverage Ratio-0.0065Theta0.0000Rho2.58Eff Leverage0.0005Vega
BriaCell Therapeutics Newsroom
BriaCell Therapeutics Analyst Ratings
BriaCell Therapeutics Analyst Ratings
BriaCell Therapeutics Analyst Ratings
H.C. Wainwright Keeps a Buy Rating on BriaCell Therapeutics (BCT)
BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright
HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Lowers Price Target to $20
BriaCell Therapeutics Analyst Ratings
BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright
BriaCell Therapeutics (BCT) Initiated With a Buy at H.C. Wainwright
BriaCell Therapeutics (BCT) Gets a Buy Rating From H.C. Wainwright
HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target
BriaCell Therapeutics Analyst Ratings
No More